157 related articles for article (PubMed ID: 34729628)
21. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe,
Ma X; Wang S; Wang S; Liu D; Zhao X; Chen H; Kang F; Yang W; Wang J; Cheng Z
J Nucl Med; 2019 Jan; 60(1):16-22. PubMed ID: 29853651
[No Abstract] [Full Text] [Related]
23. SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a
Sachindra S; Hellberg T; Exner S; Prasad S; Beindorff N; Rogalla S; Kimura R; Gambhir SS; Wiedenmann B; Grötzinger C
Front Oncol; 2021; 11():684713. PubMed ID: 34136410
[TBL] [Abstract][Full Text] [Related]
24. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
25.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
26. Initial evaluation of PET/CT with
Saga T; Nakamoto Y; Ishimori T; Inoue T; Shimizu Y; Kimura H; Akamatsu S; Goto T; Watanabe H; Kitaguchi K; Watanabe M; Ono M; Saji H; Ogawa O; Togashi K
Cancer Sci; 2019 Feb; 110(2):742-750. PubMed ID: 30549183
[TBL] [Abstract][Full Text] [Related]
27. PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides.
Liu S; Liu H; Ren G; Kimura RH; Cochran JR; Cheng Z
Theranostics; 2011; 1():403-12. PubMed ID: 22211146
[TBL] [Abstract][Full Text] [Related]
28. Biodistribution, Tumor Detection, and Radiation Dosimetry of
Young CR; Adler S; Eary JF; Lindenberg ML; Jacobs PM; Collins J; Kummar S; Kurdziel KA; Choyke PL; Mena E
J Nucl Med; 2019 Apr; 60(4):492-496. PubMed ID: 30389817
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution and radiation dosimetry of [
Hohberg M; Kobe C; Krapf P; Täger P; Hammes J; Dietlein F; Zlatopolskiy BD; Endepols H; Wild M; Neubauer S; Heidenreich A; Neumaier B; Drzezga A; Dietlein M
EJNMMI Res; 2019 Jul; 9(1):66. PubMed ID: 31346821
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Evaluation of
Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
[TBL] [Abstract][Full Text] [Related]
31. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
[TBL] [Abstract][Full Text] [Related]
33. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the diagnostic efficacy of
Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, preclinical evaluation, and first-in-human study of Al
Wu Y; Zhang X; Zhou H; Xu B; Tian J; Sun S; Zhang J
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2774-2785. PubMed ID: 35396969
[TBL] [Abstract][Full Text] [Related]
37. Preclinical Development and First-in-Human Imaging of the Integrin α
Hausner SH; Bold RJ; Cheuy LY; Chew HK; Daly ME; Davis RA; Foster CC; Kim EJ; Sutcliffe JL
Clin Cancer Res; 2019 Feb; 25(4):1206-1215. PubMed ID: 30401687
[TBL] [Abstract][Full Text] [Related]
38. FAPI-74 PET/CT Using Either
Giesel FL; Adeberg S; Syed M; Lindner T; Jiménez-Franco LD; Mavriopoulou E; Staudinger F; Tonndorf-Martini E; Regnery S; Rieken S; El Shafie R; Röhrich M; Flechsig P; Kluge A; Altmann A; Debus J; Haberkorn U; Kratochwil C
J Nucl Med; 2021 Feb; 62(2):201-207. PubMed ID: 32591493
[No Abstract] [Full Text] [Related]
39. (18)F-FDG-PET/CT findings in pancreatic metastasis.
Hu S; Zhang J; Zuo C; Cheng C; Liu Q; Sun G
Radiol Med; 2015 Oct; 120(10):887-98. PubMed ID: 25795439
[TBL] [Abstract][Full Text] [Related]
40. Combined model-based and patient-specific dosimetry for
Plyku D; Mena E; Rowe SP; Lodge MA; Szabo Z; Cho SY; Pomper MG; Sgouros G; Hobbs RF
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):989-998. PubMed ID: 29460025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]